Login Register Cart 0
Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Imperatorin Attenuates the Proliferation of MCF-7 Cells in Combination with Radiotherapy or Hyperthermia

Author(s): Peyman Amini, Saeedeh Jafari Nodooshan, Milad Ashrafizadeh, Akbar Aliasgharzadeh, Zarichehr Vakili, Saeed Tavakoli, Tayebeh Aryafar, Ahmed Eleojo Musa, Masoud Najafi*, Shahram Taeb* and Bagher Farhood*

Volume 15, Issue 3, 2022

Published on: 12 May, 2022

Page: [236 - 241] Pages: 6

DOI: 10.2174/1874471015666220318122202

Price: $65

Abstract

Background: Breast cancer is one of the most common types of malignancies in the world. Cancer resistance is an unavoidable consequence of therapy with radiation or other modalities. Ongoing research aims to improve cancer response to therapy.

Aim: The aim of this study was to evaluate the possible sensitization effect of imperatorin (IMP) in combination with external radiotherapy (ERT) or HT.

Methods: After treatment of MCF-7 breast cancer cells with IMP, cells were exposed to 4 Gy X-rays or HT (42 °C for 1 hour). The viability of MCF-7 cells was measured using an MTT assay. Furthermore, the expression of pro-apoptotic genes, including Bax, Bcl-2, caspase-3, caspase-8, and caspase- 9, was investigated using real-time PCR. The sensitizing effect of IMP in combination with ERT or HT was calculated and compared to ERT or HT alone.

Results: Results showed an increase in the expression of pro-apoptotic genes and downregulation of anti-apoptotic Bcl-2 following ERT and HT. Furthermore, cell viability was reduced following these treatments. IMP was able to augment these effects of ERT and HT.

Conclusion: IMP could increase the efficiency of HT and ERT. This effect of IMP may suggest it as an adjuvant for increasing the therapeutic efficiency of ERT.

Keywords: Imperatorin, radiotherapy, hyperthermia, MCF-7, breast cancer, apoptosis.

« Previous Next »
Graphical Abstract

[1]
Girdhani, S.; Ahmed, M.M.; Mishra, K.P. Enhancement of gamma radiation-induced cytotoxicity of breast cancer cells by curcumin. Mol. Cell. Pharmacol., 2009, 1(4), 208-217.
[2]
Nasser, M.I.; Zhu, S.; Hu, H.; Huang, H.; Guo, M.; Zhu, P. Effects of imperatorin in the cardiovascular system and cancer. Biomed. Pharmacother., 2019, 120, 109401.
[PMID: 31622950]
[3]
You, C.; Yang, Y.; Gao, B. Imperatorin targets MCL-1 to sensitize CD133+ lung cancer cells to γδ-T cell-mediated cytotoxicity. Cell. Physiol. Biochem., 2018, 49(1), 235-244.
[4]
Rahman, A.; Siddiqui, S.A.; Jakhar, R.; Kang, S.C. Growth inhibition of various human cancer cell lines by imperatorin and limonin from Poncirus trifoliata rafin seeds. Anticancer. Agents Med. Chem., 2015, 15(2), 236-241.
[PMID: 25244913]
[5]
Zheng, Y.M.; Lu, A.X.; Shen, J.Z.; Kwok, A.H.; Ho, W.S. Imperatorin exhibits anticancer activities in human colon cancer cells via the caspase cascade. Oncol. Rep., 2016, 35(4), 1995-2002.
[6]
Lee, H.; Park, H.J.; Park, C-S.; Oh, E-T.; Choi, B-H.; Williams, B.; Lee, C.K.; Song, C.W. Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined. PLoS One, 2014, 9(2), e87979.
[PMID: 24505341]
[7]
Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 2001, 29(9), e45.
[PMID: 11328886]
[8]
Metelmann, H.R.; Seebauer, C.; Rutkowski, R.; Schuster, M.; Bekeschus, S.; Metelmann, P. Treating cancer with cold physical plasma: On the way to evidence‐based medicine. Contrib. Plasma Phys., 2018, 58(5), 415-419.
[9]
Baudino, A.T. Targeted cancer therapy: the next generation of cancer treatment. Curr. Drug Discov. Technol., 2015, 12(1), 3-20.
[10]
Pucci, C.; Martinelli, C.; Ciofani, G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience, 2019, 13, 961.
[PMID: 31537986]
[11]
Appendino, G.; Bianchi, F.; Bader, A.; Campagnuolo, C.; Fattorusso, E.; Taglialatela-Scafati, O.; Blanco-Molina, M.; Macho, A.; Fiebich, B.L.; Bremner, P. Coumarins from Opopanax c hironium. New Dihydrofuranocoumarins and differential induction of apoptosis by impe-ratorin and heraclenin. J. Nat. Prod., 2004, 67(4), 532-536.
[PMID: 15104479]
[12]
Sancho, R.; Márquez, N.; Gómez-Gonzalo, M.; Calzado, M.A.; Bettoni, G.; Coiras, M.T.; Alcamí, J.; López-Cabrera, M.; Appendino, G.; Muñoz, E. Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J. Biol. Chem., 2004, 279(36), 37349-37359.
[PMID: 15218031]
[13]
Luszczki, J.J.; Glowniak, K.; Czuczwar, S.J. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maxi-mal electroshock-induced seizures in mice. Eur. J. Pharmacol., 2007, 574(2-3), 133-139.
[PMID: 17651727]
[14]
Bądziul, D.; Jakubowicz-Gil, J.; Paduch, R.; Głowniak, K.; Gawron, A. Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells. Mol. Cell. Biochem., 2014, 392(1-2), 213-227.
[PMID: 24682729]
[15]
Min, J.; Yuan, L.; Hai-Liang, X.; Ting-Ting, H. Estrogenic activity of osthole and imperatorin in MCF-7 cells and their osteoblastic effects in Saos-2 cells. Chin. J. Nat. Med., 2016, 14(6), 413-420.
[PMID: 27473958]
[16]
Yang, H-L.; Chen, C-S.; Chang, W-H.; Lu, F-J.; Lai, Y-C.; Chen, C-C.; Hseu, T-H.; Kuo, C-T.; Hseu, Y-C. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett., 2006, 231(2), 215-227.
[PMID: 16399223]
[17]
Safarzadeh, E.; Shotorbani, S.S.; Baradaran, B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull., 2014, 4(Suppl. 1), 421-427.
[PMID: 25364657]
[18]
Frisch, S.M.; Screaton, R.A. Anoikis mechanisms. Curr. Opin. Cell Biol., 2001, 13(5), 555-562.
[PMID: 11544023]
[19]
Vali, F.; Changizi, V.; Safa, M. Synergistic apoptotic effect of crocin and paclitaxel or crocin and radiation on MCF-7 cells, a type of breast cancer cell line. Int. J. Breast Cancer, 2015, 2015, 139349.
[PMID: 26693354]
[20]
Anghileri, L.J.; Robert, J. Hyperthermia in cancer treatment; CRC Press, 2019.
[21]
Elming, P.B.; Sørensen, B.S.; Oei, A.L.; Franken, N.A.; Crezee, J.; Overgaard, J.; Horsman, M.R. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers (Basel), 2019, 11(1), 60.
[PMID: 30634444]
[22]
Lee, T.H.; Bu, J.; Kim, B.H.; Poellmann, M.J.; Hong, S.; Hyun, S.H. Sub-lethal hyperthermia promotes epithelial-to-mesenchymal-like transition of breast cancer cells: implication of the synergy between hyperthermia and chemotherapy. RSC Advances, 2019, 9(1), 52-57.
[23]
Liao, S.; Hu, X.; Liu, Z.; Lin, Y.; Liang, R.; Zhang, Y.; Li, Q.; Li, Y.; Liao, X. Synergistic action of microwave-induced mild hyperthermia and paclitaxel in inducing apoptosis in the human breast cancer cell line MCF-7. Oncol. Lett., 2019, 17(1), 603-615.
[PMID: 30655807]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy